CN Patent

CN109503694A — 一种新型gabaa受体调节剂及其用途

Assigned to Suzhou Wentian Medical Technology Co Ltd · Expires 2019-03-22 · 7y expired

What this patent protects

本发明涉及一种神经甾体类新型GABA A 受体调节剂及其药学上可接受的盐或酯及用于相关CNS疾病的治疗。本发明的化合物具有良好的生物活性和优秀的PK性质，该新型化合物有非常大的潜力作为口服CNS疾病治疗药物。

USPTO Abstract

本发明涉及一种神经甾体类新型GABA A 受体调节剂及其药学上可接受的盐或酯及用于相关CNS疾病的治疗。本发明的化合物具有良好的生物活性和优秀的PK性质，该新型化合物有非常大的潜力作为口服CNS疾病治疗药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN109503694A
Jurisdiction
CN
Classification
—
Expires
2019-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Wentian Medical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.